<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02255812</url>
  </required_header>
  <id_info>
    <org_study_id>EKBB 289/12/2</org_study_id>
    <nct_id>NCT02255812</nct_id>
  </id_info>
  <brief_title>Taste Physiology in Healthy, Normal-weight Volunteers</brief_title>
  <official_title>Taste Physiology in Healthy, Normal-weight Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Taste physiology describes five main taste qualities in humans: sweet, sour, salty, umami and
      bitter. The receptors found on the tongue are also found in the entire gut. The correlation
      of stimulation of these gut receptors and brain activity has not yet been examined. The
      objectives are to investigate the effect of different taste substances on i) regional brain
      activity and ii) satiation peptide release.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>regional brain activity assessed by functional Magnetic Resonance Imaging (fMRI)</measure>
    <time_frame>changes from baseline to one hour after treatment</time_frame>
    <description>Changes in resting state functional connectivity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>gastrointestinal satiation peptide secretion</measure>
    <time_frame>changes from baseline to one hour after treatment</time_frame>
    <description>Unit of Measure: glucagon like peptide-1 (GLP-1) in pg/mL, peptide tyrosine tyrosine (PYY) in pg/mL and gastric inhibitory polypeptide (GIP) in pg/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose and insulin secretion</measure>
    <time_frame>changes from baseline to one hour after treatment</time_frame>
    <description>Unit of Measure: glucose in mmol/L, insulin in Î¼U/mL</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Exploratory Behavior</condition>
  <arm_group>
    <arm_group_label>200 mL tap water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single intragastric instillation of 200 mL tap water via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 g citric acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 2 g citric acid in 200 mL tap water via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 g salt</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 2 g salt in 200 mL tap water via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.017 g quinine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 0.017 g quinine in 200 mL tap water via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 g monosodium glutamate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 1 g monosodium glutamate in 200 mL tap water via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>25 g glucose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 25 g glucose in 200 mL tap water via nasogastric tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Single intragastric instillation of 200 mL tap water via nasogastric tube</intervention_name>
    <arm_group_label>200 mL tap water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Single intragastric instillation of 2 g citric acid in 200 mL tap water via nasogastric tube</intervention_name>
    <arm_group_label>2 g citric acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Single intragastric instillation of 2 g salt in 200 mL tap water via nasogastric tube</intervention_name>
    <arm_group_label>2 g salt</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Single intragastric instillation of 0.017 g quinine in 200 mL tap water via nasogastric tube</intervention_name>
    <arm_group_label>0.017 g quinine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Single intragastric instillation of 1 g monosodium glutamate in 200 mL tap water via nasogastric tube</intervention_name>
    <arm_group_label>1 g monosodium glutamate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Single intragastric instillation of 25 g glucose in 200 mL tap water via nasogastric tube</intervention_name>
    <arm_group_label>25 g glucose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  right-handed healthy males

          -  Body-mass index of &lt; 25

          -  Age 18-45 years

          -  no drugs

          -  non-smoking

        Exclusion Criteria:

          -  Smoking

          -  Substance abuse

          -  Regular intake of medications (except for oral contraceptives)

          -  Medical or psychiatric illness, especially: diabetes, pace-maker, claustrophobia

          -  History of gastrointestinal disorders

          -  Food allergies, glutamate intolerance

          -  Body piercings that cannot be removed
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Beglinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Basel</city>
        <zip>CH-4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2014</study_first_submitted>
  <study_first_submitted_qc>September 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2014</study_first_posted>
  <last_update_submitted>September 30, 2014</last_update_submitted>
  <last_update_submitted_qc>September 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quinine</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

